January 23, 2013

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

Poor arthritis outcome risk up in overweight black women

Overweight African-American women with or at risk of knee osteoarthritis are at higher risk than overweight white women of poor functional outcomes, according to a study published in the January issue of Arthritis Care & Research.
× close
Overweight African-American women with or at risk of knee osteoarthritis are at higher risk than overweight white women of poor functional outcomes, according to a study published in the January issue of Arthritis Care & Research.

(HealthDay)—Overweight African-American women with or at risk of knee osteoarthritis are at higher risk than overweight white women of poor functional outcomes, according to a study published in the January issue of Arthritis Care & Research.

Carmelita J. Colbert, M.D., from Northwestern University in Chicago, and colleagues analyzed whether excess body weight was associated with poorer four-year functional outcomes (as determined by the Western Ontario and McMaster Universities Index function, 20-meter walk and chair stand performance) in African-Americans compared with whites in 3,695 patients (16.1 percent African-American) with or at higher risk for .

The researchers found that a higher body mass index and large waist circumference correlated with poorer outcomes. Among women with either feature, African-American women had a higher risk of poor outcomes, after adjusting for age, education, and income. The findings were potentially explained by income, comorbidity, depressive symptoms, pain, and disease severity. For men, findings were less consistent and were potentially explained by age and knee pain.

"Among Osteoarthritis Initiative women with excess body weight, African-Americans are at greater risk than whites for poor four-year outcome," Colbert and colleagues conclude. "Modifiable factors that may help to explain these findings in the Osteoarthritis Initiative include comorbidity, depressive symptoms, and knee pain."

The study was partially funded by Merck, Novartis, GlaxoSmithKline, and Pfizer as part of the Osteoarthritis Initiative, a public-private partnership.

More information: Abstract
Full Text

Journal information: Arthritis Care & Research

Load comments (0)